TrumpBacked Challenger Unseats Incumbent Senator Political Risk Weighs on Market Sentiment Sebi Weighs Opening Bullion Derivatives to Foreign Portfolio Investors Should You Sell Luxfer LXFR After 109 Drop 20260515 LGI Homes LGIH Q1 2026 Earnings Surprise EPS 024 Up Significant Powell Vows No Shadow Chair Role but Return of Former Fed Leader Warsh Could Stir Tensions US Official Alleges Japans Role in Fentanyl Smuggling Raising Trade and Compliance Concerns Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives Pokmon Card Market Booms on Nostalgia and Speculation Inside the MultiMillion Dollar Trading Frenzy US Advocacy Groups Call for Investigation into Roblox Over Child Safety and InGame Spending Concerns Prediction Market Investments Surge Amid Regulatory Uncertainty RYZ Q1 2026 Earnings EPS Misses Estimates Sharply Stock Gains Nearly 5 Daily Journal Corp DJCO Q4 2025 Earnings EPS Surges to 3061 on Investment Gains Stock Edges Higher Spectral AI Inc MDAI Q1 2026 Earnings WiderThanExpected Loss Amid Absent Revenue Disclosure TTGT Q1 2026 Earnings Significant EPS Miss Sends Stock Higher ISBA Q1 2026 Earnings Massive EPS Miss Drives Stock Decline AMRZ Q1 2026 Earnings EPS Misses Estimates by 5441 Shares Rise 321 AEAQW Gains Momentum Activate Energy Warrant Shows 526 Uptick Amid Speculation AMREP Corporation AXR Surges 765 Breaking Past Key Levels or Facing Resistance Ahead Acacia Research ACTG Edges Higher Testing Key Support Zone InMed Pharmaceuticals INM Holds Near Support Amid Quiet Trading Session Philip Morris International Edges Lower as Stock Consolidates Near Key Levels Traders Eye IonQ Micron Anduril as Potential Next Targets for US Government Stakes SpaceX IPO Filing Draws Market Attention KraneShares AGIX Offers Indirect Space Exposure DWave Shares Surge 44 on Government Support Announcement BristolMyers Squibb BMY Gains Hedge Fund Favor with 425 Dividend Yield and AI Partnership Nvidia Stock Approaches Critical Technical Level Traders Eye Potential Breakout Meta Cloud Computing Business Definitely on the Table Says CEO Zuckerberg COST Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Stoke Therapeutics STOK Sees Minor Decline as Shares Test Support Near 28 Level